Jose Luis Martinez Email & Phone Number

Tokyo, Jp

Leverkusen, North Rhine-Westphalia, De

- Role expansion. I am in charge of creating internal readiness and external preparedness of 3 new future indications extending Stivarga LoE for 8 additional years

Leverkusen, North Rhine-Westphalia, De

In charge of Stivarga, brand with 3 indications. Made the brand return to grow through different initiatives:- Bend the Trend: new messaging and extensive field force training to prepare before new competitors - New campaign co- development with Global- Competitive Response plan- KOL management, and - Smart Digital pull through

Leverkusen, North Rhine-Westphalia, De

Supported the launch of Nubeqa and growth of Xofigo in Brazil, Mexico, South Cone (Arg, Chi, Uru, Par) and PACA (Colombia, Central America and Caribbean)

Leverkusen, North Rhine-Westphalia, De

Leading a team of 10, including 4 direct reports, all of them Sr. Product Managers and a First Line Sales Manager (team to be expanded with each launch). I support the Prostate Franchise including Xofigo (an alpha radio therapy) and Nubeqa (ARi, future blockbuster) and Vitrakvi (first Agnostic drug to be commercialize)

Leverkusen, North Rhine-Westphalia, De

- Manage the TKI Oncology portfolio of Bayer for a total of 6 indications (Colorectal, GIST, Hepatocellular 1st and 2nd line, Renal and Thyroid cancer), accounting for ~85% of Bayer Oncology portfolio sales. Brands: Nexavar and Stivarga.- I led a team of 18 including 2 PM, 2 FLSM and 14 sales consultants and 1 traineeAchievements: - Managed the TKI Oncology portfolio at Bayer for a total of 6 indications accounting for ~55% of Bayer Specialty Medicine portfolio sales. Full P&L responsibility. Franchise’s topline increased 25% and EBIT increased from 26 to 38% in 2Y - Successful LoE management of Nexavar through legal strategies, second brand and migration from product to services- Launched Stivarga HCC2L Indication in August 2017 and obtained reimbursement in July 2018

Leverkusen, North Rhine-Westphalia, De

Leverkusen, North Rhine-Westphalia, De

Leverkusen, North Rhine-Westphalia, De

Switzerland 🇨🇭 , Ch

- Leader in charge of coordinating the strategy against biosimilar drugs from a legal, regulatory and market viewpoint, in order to protect Roche's biotech drugs, especially monoclonal antibodies from intended copies unfair competition. Competitors product was removed from the local market, leaving Roche with MabThera as the only product in the Mexican market

Switzerland 🇨🇭 , Ch

International accelerated talent management rotational program, 4 assignments:03.2011 - 08.2011 Roche Molecular Diagnostics @ Pleasanton, US09.2011 - 02.2012 Roche Professional Diagnostics @ Rotkreuz, CH03.2012 - 08.2012 Roche Diagnostics India @ Mumbai, IN08.2012 - 02.2013 Roche Diagnostics LatAm @ Sao Paulo, BR

Louisville, Ky, Us

Ciudad De México, Mx

Stockholm, Se

Mexico D.F, Mx

Market researcher

Master'S Degree, Business Administration And Management, General

Mba (Exchange), Exchange Term

Lae, Bsc Administration

International Management Program, Marketing/Marketing Management, General